FDC P/E Ratio

FDC • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
24.66
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 24.66
Current Price ₹340.60
EPS (TTM) ₹16.39
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.03
Historical Range 11.7 - 38.37
Percentile 71.4%

Sector Context

Sector Average 47.66
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹13.32
Sept 2025 ₹1.75
Mar 2025 ₹2.38

Key P/E Ratio Insights for FDC

  • Trading at discount to sector average PE of 47.66

P/E Ratio Historical Trend for FDC

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 38.37 13.32 ₹511.10 NSE High
2024 23.38 16.86 ₹394.20 NSE Moderate
2023 15.68 17.55 ₹275.10 NSE Moderate
2022 29.16 10.4 ₹303.30 NSE High
2021 22.24 14.96 ₹332.75 NSE Moderate
2020 11.7 18.18 ₹212.75 NSE Low
2019 13.66 12.67 ₹173.05 NSE Low

Sector P/E Ratio Comparison

Comparing FDC with other companies in Healthcare sector
Sector Average
47.66
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low